BioVid

Decoding Behavior for Good

Scroll with rubber stamp

Our Mission

BioVid partners with life science organizations to solve business problems in support of the greater good. We provide creative-yet-practical business solutions through strategic consulting, best-in-class research, and smart design for leading pharmaceutical and medical device organizations around the world.

Our Latest Innovations

Your Market Will Change – Your Segmentation Doesn’t Have to

We understand the durability problem that faces life science segmentations, and we have found a way to overcome it. Discover the next stage of evolution in segmentation studies: BioVid’s Four Cornerstones.

BioVid is the Demand Partner You Need

We use the science of prediction to sidestep conventional sources of invalidity and inflationary biases. This has allowed us to accurately estimate in-market peak share to within a few percentage points in 90% of our validated cases.

We Make Predicting the Future Look Easy

The experts in our Prediction Center of Excellence have created a suite of evidence-based techniques to help clients make sense of future trends, make better predictions, and make more accurate forecasts.

Time is Money: Mitigate Risks in Clinical Trials Research

Clinical trials are fraught with risks and lack engagement from key stakeholders – leaving you short on time and money. Our three offerings help mitigate those financial and timeline risks by drawing on cognitive and behavioral science and advanced analytics to bring you deep-seated answers to your most pressing clinical research questions.

Our Team

Our people are more than the roles they play at work.

We see our team like we see patients, physicians, and consumers – as humans first. We employ living, breathing, complex human beings with diverse experiences, needs, desires, and struggles. We respect and celebrate their humanness. We aim to attract people who are passionately curious about understanding what it means to be human. We use our diverse life experiences and perspectives to help inform how we work together to solve problems for the world’s leading life sciences organizations. 

Our Thoughts

The EMA’s Phased Review Signals More Than Faster Approvals: It Changes How Companies Should Plan for Launch

| Author: Alison Kneen, Global Market Access Practice Lead, BioVid The timeline between clinical development and commercial launch is shrinking. Not...

Three things I’m watching at ASCO 2026

As we head to Chicago for ASCO 2026, the most critical questions go beyond which trials met their primary endpoints. They are about what happens...

The Knowledge Broker’s Advantage: Market Research in the Age of Infinite Information

Author: Gregg Quy, Senior Director, Insights & Strategy There is a famous story about Michelangelo. Asked how he created such transcendent...

Understanding Geopolitical Influence and the U.S. Most Favored Nation Health Policy on Market Access Strategy

| Author: Alison Kneen, Global Market Access Practice Lead, BioVid Geopolitics is crucial to understand in today’s pharmaceutical market. This week...

Why an Oncology CoE? Because Complexity Has Outpaced Human Capacity.

A widening synthesis gap - the distance between the overwhelming volume of clinical data and a team's ability to translate it into a winning...

Your Patient Has Three Brains. Your Research Only Reaches One, Maybe Two.

Patients can't fully explain their own health decisions. Much of the processing happens before conscious thought, and standard research misses the...

Beyond the Data: Why the Next Phase of ADC Success is Behavioral, Not Biological

For decades, oncology has pursued the ‘magic bullet,' precision therapies that selectively eradicate tumors while sparing healthy tissue....

Your Customers Already Have a Third Brain. Now What?

A new paper out of Wharton should change how you think about every piece of AI-inclusive research you have run this year. Shaw and Nave ran three...

When Trade Policy Meets Drug Pricing: Why Market Access Strategy Must Evolve

Author: Alison Kneen, Global Market Access Practice Lead, BioVid Recent developments surrounding U.S. Most Favored Nation (MFN) pricing discussions...

Ireland’s Strategic Shift: Navigating New Market Access Opportunities in a Changing Geopolitical Landscape

Author: Alison Kneen, Global Market Access Lead, BioVid In the wake of recent geopolitical shifts, Ireland has taken decisive steps to ensure rapid...

Global Market Access 2025: Strategic Imperatives for 2026 and Beyond

Author: Alison Kneen, Global Market Access Practice Lead This year has seen more changes in market access than in the last few decades. The market...

Hope: A Beacon for Patients Living with Chronic Diseases

In the murky waters of chronic illness, hope can be a life raft. It can be an anchor that keeps a patient afloat when treatment feels like a storm;...

The Loneliness Equation: A Market Maze for Healthcare

Loneliness is not just a fleeting pang after a canceled movie night. It's a chronic, silent epidemic gripping our societies, with profound...

The Cognitive Equation for Pessimism in Chronic Disease: A Patient-Centered Perspective

Equation: Pessimism = Anticipation + SadnessFor patients navigating the challenges of chronic illness, pessimism often casts a long shadow. In...

Context Shapes Mindsets: The Case for People as “Predictably Contextual”

Dan Ariely's concept of "predictably irrational" has gained considerable attention, suggesting that people's behaviors are driven by inherent...

Conformity: A Powerful Force in Pharmaceutical Markets

Equation: Conformity = Norm Awareness + Imitative ActionIn the dynamic world of pharmaceuticals, understanding human behavior is crucial for...

The Timeless Power of Persuasion: Using Human Truths to Enhance Market Strategies

In an age of rapid technological advancements, ever-evolving digital landscapes, and shifting consumer behavior, one might assume that the art of...

Navigating the Suspense of Chronic Diseases: Uncertainty, Hope, and Fear

In our Dictionary of Cognitive Equations, we offer a formula for Suspense — an experience prevalent among individuals living with intense chronic...

The Impact of Meaninglessness on Despair

Equation: Despair = Suffering - Meaning Viktor Frankl, an Austrian psychiatrist and Holocaust survivor, dedicated his life to understanding the...

Cultural Cooling in Medical Care

The Impacts of Patient Hostility on American Doctors and Implications for the Pharmaceutical Industry

Finding Goldilocks Participants to Help Us Make Better Predictions in Life Science

The second post in our series on business prediction Can humans do a good job predicting complex outcomes in different life and business domains? If...

Why We Need Humans to Help Us Predict Market Evolution

Our first post in a series about the importance of Prediction Science and its implications for product forecasting and business decision-making In...

Stop “Guesstimating” Your Product’s Future Market Share

Discover our proven, science-based system for accurately measuring product demand. View the infographic below, and contact us for more info.

Stay Up To Date:

We periodically send email updates announcing new business solutions, forward-thinking insights, live events, and more. Sign up for our newsletter to stay up to date on the latest BioVid news.​

    Contact Us